Skip to main content
Top
Published in: World Journal of Surgery 1/2007

01-01-2007

Postoperative Glycemic Control after Central Pancreatectomy for Mid-gland Lesions

Authors: John D. Allendorf, MD, Beth A. Schrope, MD, Margaret H. Lauerman, BS, William B. Inabnet, MD, John A. Chabot, MD

Published in: World Journal of Surgery | Issue 1/2007

Login to get access

Abstract

Introduction

Patients undergoing partial pancreatectomy are at risk for developing surgically induced diabetes. Patients with lesions in the neck and body of the pancreas are at increased risk because traditional resectional approaches (pancreaticoduodenectomy or distal pancreatectomy) must be extended to remove the tumor with adequate margins. Increasingly, we have been performing pancreatic parenchyma-sparing resections (central pancreatectomy with pancreaticogastrostomy) in an effort to reduce the risk of postpancreatectomy endocrine insufficiency.

Methods

The operative records of patients who underwent pancreatectomy at our institution from 1999 to 2005 were reviewed. We identified 26 patients who underwent central pancreatectomy with pancreaticogastrostomy reconstruction for cystic lesions (n = 23), neuroendocrine tumors (n = 2), and Frantz’s tumor (n = 1). Charts were reviewed for patient demographics, volume of resection, complications, and evaluation of postoperative glycemic control.

Results

The mean follow-up was 33 months (range 3–72 months). The average volume of pancreas resected was 49.6 ± 38.6 cm3, and the mean diameter of the lesions was 2.6 ± 1.5 cm. Nine complications occurred in eight patients (overall morbidity 31%), and the average length of stay was 6.9 ± 2.7 days. Pancreatic leaks (n = 2; 7.7%) were successfully managed nonoperatively. There was no operative mortality, and there has been no tumor recurrence. None of the patients were diabetic preoperatively. Postoperatively, two (7.7%) developed endocrine insufficiency with a mean postoperative hemoglobin A1c (HbA1c) value of 7.65%. Neither patient has required exogenous insulin. HbA1c in the remaining patients was 5.9% ± 0.5%.

Conclusions

Pancreatic parenchyma-sparing surgery for lesions in the midportion of the gland can be performed with acceptable morbidity. Postoperative glycemic control after pancreatic parenchyma-sparing surgery compares favorably with that reported for patients with traditional resections.
Literature
2.
go back to reference Rotman N, Sastre B, Pierre-Louis F. Medial pancreatectomy for tumors of the neck of the pancreas. Surgery 1993;113:532–535PubMed Rotman N, Sastre B, Pierre-Louis F. Medial pancreatectomy for tumors of the neck of the pancreas. Surgery 1993;113:532–535PubMed
3.
go back to reference Iacono C, Bortolasi L, Serio G. Is there a place for central pancreatectomy in pancreatic surgery? J Gastrointest Surg 1998;2:509–517PubMedCrossRef Iacono C, Bortolasi L, Serio G. Is there a place for central pancreatectomy in pancreatic surgery? J Gastrointest Surg 1998;2:509–517PubMedCrossRef
4.
go back to reference Sperti C, Pasquali C, Ferronato A, et al. Median pancreatectomy for tumors of the neck of the pancreas. J Am Coll Surg 2000;190:711–715PubMedCrossRef Sperti C, Pasquali C, Ferronato A, et al. Median pancreatectomy for tumors of the neck of the pancreas. J Am Coll Surg 2000;190:711–715PubMedCrossRef
5.
go back to reference Goldstein MG, Toman J, Chabot JA. Pancreaticogastrostomy: a novel application after central pancreatectomy. J Am Coll Surg 2004;98:871–876CrossRef Goldstein MG, Toman J, Chabot JA. Pancreaticogastrostomy: a novel application after central pancreatectomy. J Am Coll Surg 2004;98:871–876CrossRef
6.
go back to reference Efron D, Lillemoe KD, Cameron JL, et al. Central pancreatectomy with pancreaticogastrostomy for benign pancreatic pathology. J Gastrointest Surg 2004;8:532–538PubMedCrossRef Efron D, Lillemoe KD, Cameron JL, et al. Central pancreatectomy with pancreaticogastrostomy for benign pancreatic pathology. J Gastrointest Surg 2004;8:532–538PubMedCrossRef
7.
go back to reference Sauvanet A, Partensky C, Sastre B, et al. Medial pancreatectomy: a multi-institutional retrospective study of 53 patients by the French Pancreas Club. Surgery 2002;132:836–843PubMedCrossRef Sauvanet A, Partensky C, Sastre B, et al. Medial pancreatectomy: a multi-institutional retrospective study of 53 patients by the French Pancreas Club. Surgery 2002;132:836–843PubMedCrossRef
8.
go back to reference Letton AH, Wilson JP. Traumatic severance of pancreas treated by Roux-en-Y anastomosis. Surg Gynecol Obstet 1959;109:473–478PubMed Letton AH, Wilson JP. Traumatic severance of pancreas treated by Roux-en-Y anastomosis. Surg Gynecol Obstet 1959;109:473–478PubMed
9.
go back to reference Guillemin P, Bessot M. Pancreatite calcifiante chez un tuberculeux renal: pancreato-jejunostomie selon une technique originale. Mem Acad Chirurg 1957;83:869–871 Guillemin P, Bessot M. Pancreatite calcifiante chez un tuberculeux renal: pancreato-jejunostomie selon une technique originale. Mem Acad Chirurg 1957;83:869–871
10.
go back to reference Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Ann Surg 2000;232:419–429PubMedCrossRef Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Ann Surg 2000;232:419–429PubMedCrossRef
11.
go back to reference Balcom JH, Rattner DW, Warshaw AL, et al. Ten-year experience with 733 pancreatic resections. Arch Surg 2001;136:391–398PubMedCrossRef Balcom JH, Rattner DW, Warshaw AL, et al. Ten-year experience with 733 pancreatic resections. Arch Surg 2001;136:391–398PubMedCrossRef
12.
go back to reference Sun AM, Coddling JA, Haist RE. A study of glucose tolerance and insulin response in partially depancreatized dogs. Diabetes 1974;23:424–432PubMed Sun AM, Coddling JA, Haist RE. A study of glucose tolerance and insulin response in partially depancreatized dogs. Diabetes 1974;23:424–432PubMed
13.
14.
go back to reference Jalleh RP, Williamson RCN. Pancreatic exocrine and endocrine function after operations for chronic pancreatitis. Ann Surg 1992;216:656–662PubMedCrossRef Jalleh RP, Williamson RCN. Pancreatic exocrine and endocrine function after operations for chronic pancreatitis. Ann Surg 1992;216:656–662PubMedCrossRef
15.
go back to reference Slezak LA, Anderson DK. Pancreatic resections: effects on glucose metabolism. World J Surg 2001;25:452–460PubMedCrossRef Slezak LA, Anderson DK. Pancreatic resections: effects on glucose metabolism. World J Surg 2001;25:452–460PubMedCrossRef
16.
go back to reference Hutchins RR, Hart RS, Pacifico M. Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients. Ann Surg 2002;236:612–618PubMedCrossRef Hutchins RR, Hart RS, Pacifico M. Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients. Ann Surg 2002;236:612–618PubMedCrossRef
17.
go back to reference Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567–579PubMedCrossRef Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567–579PubMedCrossRef
18.
go back to reference Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996;223:506–511PubMedCrossRef Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996;223:506–511PubMedCrossRef
19.
go back to reference Balzano G, Zerbi A, Veronesi P, et al. Surgical treatment of benign and borderline neoplasms of the pancreatic body. Dig Surg 2003;20:506–510PubMedCrossRef Balzano G, Zerbi A, Veronesi P, et al. Surgical treatment of benign and borderline neoplasms of the pancreatic body. Dig Surg 2003;20:506–510PubMedCrossRef
20.
go back to reference Sperti C, Pasquali C, Piccoli A, et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 1996;83:625–631PubMed Sperti C, Pasquali C, Piccoli A, et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 1996;83:625–631PubMed
21.
go back to reference Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery: risk factors influencing the short-term results. Ann Surg 1993;217:356–368PubMedCrossRef Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery: risk factors influencing the short-term results. Ann Surg 1993;217:356–368PubMedCrossRef
22.
go back to reference Williamson RC, Cooper MJ. Resection in chronic pancreatitis. Br J Surg 1987;74:807–812PubMed Williamson RC, Cooper MJ. Resection in chronic pancreatitis. Br J Surg 1987;74:807–812PubMed
23.
go back to reference Keith RG, Saibil FG, Sheppard RH. Treatment of chronic alcoholic pancreatitis by pancreatic resection. Am J Surg 1989;157:156–162PubMedCrossRef Keith RG, Saibil FG, Sheppard RH. Treatment of chronic alcoholic pancreatitis by pancreatic resection. Am J Surg 1989;157:156–162PubMedCrossRef
24.
go back to reference Morrow ME, Cohen JI, Sutherland DE, et al. Chronic pancreatitis: long-term surgical results of pancreatic duct drainage, pancreatic resection, and near-total pancreatectomy and islet transplantation. Surgery 1984;96:608–614PubMed Morrow ME, Cohen JI, Sutherland DE, et al. Chronic pancreatitis: long-term surgical results of pancreatic duct drainage, pancreatic resection, and near-total pancreatectomy and islet transplantation. Surgery 1984;96:608–614PubMed
25.
go back to reference Brunicardi FC, Chaiken RL, Ryan AS, et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 1996;81:3566–3572PubMedCrossRef Brunicardi FC, Chaiken RL, Ryan AS, et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 1996;81:3566–3572PubMedCrossRef
Metadata
Title
Postoperative Glycemic Control after Central Pancreatectomy for Mid-gland Lesions
Authors
John D. Allendorf, MD
Beth A. Schrope, MD
Margaret H. Lauerman, BS
William B. Inabnet, MD
John A. Chabot, MD
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 1/2007
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-0382-5

Other articles of this Issue 1/2007

World Journal of Surgery 1/2007 Go to the issue